Remitly

RELY

Market cap $3.97B

SEATTLE, April 10, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”) today announced the appointment of Adam Messinger to its Board of Directors (the “Board”). With this appointment, Remitly is increasing the size of its Board from 10 to 11 directors. In connection with his appointment, Mr. Messinger also joins the Talent and Compensation Committee of the Board.

Let's take a look at four stocks, RELY, MG, BTSG and CSTM, with stellar net profit margins and rising EPS estimates that can help create a winning portfolio.

Shares of UiPath have suffered as investors rethink the value of artificial intelligence, but this company's solutions serve a proven, marketable purpose. Remitly Global has found a great niche and perfected the way it serves it.

Oscar Health is gaining market share in health insurance. Adyen is a dominant player in enterprise payment processing.

Phibro Animal Health, Deluxe, Remitly Global and BrightSpring Health Services, Inc. (BTSG) represent four compelling small-cap stocks.

Cash is fading fast, and mobile payments are taking over everything from retail checkouts to cross-border transfers. JPMorgan Chase, Block, Jack Henry and Remitly are positioned to ride the boom.

Joshua Hug sold 29,049 shares for a transaction value of $522,301.02 on March 4, 2026. The sale represented 0.81% of his direct holdings at the time of the transaction.

RELY, MG, ENVA and SNEX boast strong net margins, rising earnings and bullish analyst ratings that signal upside.

12,000,000 common shares were sold indirectly for a transaction value of approximately $191.8 million on March 12, 2026. The sale represented 47.17% of Naspers Ltd's indirect Remitly holdings, reducing the total indirect position from 25,441,745 to 13,441,745 shares.

Remitly is facing a narrative disruption, but is actually the disruptor. It should keep growing its share of the remittance market and is expanding into new product categories.